Oxford R21/Matrix-M™ malaria vaccine receives WHO recommendation for use paving the way for global roll-out

Published on 2 October 2023

The highly effective vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax’s adjuvant is critical to reducing over half a million malaria-related deaths annually.
Continue reading on website
Other news

Oxford research on poverty, unemployment, terrorism and global kleptocracy celebrated for real-world impacts

2 October 2023
Four extraordinary projects involving Oxford academics, which bring research impact to real-world issues, have today been shortlisted for a prestigious ‘Celebrating Impact Prize’ by the government’s Economic and Social Research Council.  Three individuals and one team project, including Oxford researchers, have been chosen because of the ‘outstanding economic or societal impact’ of their research.

New research finds that reducing antibiotic usage in animal feed is not enough to combat antibiotic resistance

2 October 2023
A new study led by the University of Oxford has found that natural evolution of antibiotic resistance genes has maintained resistance in bacteria despite a reduction in the use of antibiotics. The findings demonstrate the importance of understanding the regulatory evolution of resistance genes to strategically combat AMR. The study has been published in the Journal of the International Society for